Werbung
Werbung

ANRO

ANRO logo

Alto Neuroscience Inc.

17.22
USD
Gesponsert
+1.33
+8.37%
09. Jan., 12:43 UTC -5
Offen

ANRO Ergebnisberichte

Positives Überraschungsverhältnis

ANRO übertreffen die 5 der letzten 8Schätzungen.

63%

Nächster Bericht

Datum des nächsten Berichts
20. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.54
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/
+3.85%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/
-3.57%

Alto Neuroscience Inc. earnings per share and revenue

On 12. Nov. 2025, ANRO reported earnings of -0.52 USD per share (EPS) for Q3 25, beating the estimate of -0.68 USD, resulting in a 23.65% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +5.97% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analysts forecast an EPS of -0.54 USD, with revenue projected to reach -- USD, implying an increase of 3.85% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, Alto Neuroscience Inc. reported EPS of -$0.52, beating estimates by 23.65%, and revenue of $0.00, 0% as expectations.
The stock price moved up 5.97%, changed from $13.40 before the earnings release to $14.20 the day after.
The next earning report is scheduled for 20. März 2026.
Based on 12 analysts, Alto Neuroscience Inc. is expected to report EPS of -$0.54 and revenue of -- for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung